Company / SG&A per Share
Enovis SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$18.71
FY2025
5-year range
$5.62 / $18.82
FY2021-FY2025
Trend
-0.6%
vs FY2024
Sector context
#24 of 156
Health Care
What the data says
Enovis's sg&a per share of $18.71 is higher than 85% of companies in the Health Care sector (FY2025). SG&A per Share has fluctuated over the past 10 years, ranging from $4.27 in FY2019 to $18.82 in FY2024.
Based on SEC 10-K filings.
18.71 in FY2025 with a 5-year CAGR of +32.1%. Top quartile in the Health Care sector.
Increased from $12.28 to $18.71 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +23.7%
- 5-Year CAGR
- +32.1%
- 10-Year CAGR
- -
Sector benchmark
Bottom 15% in Health CareTop 85% of 156This company $18.71 Sector average $11421.56
▼
-99.8% below sector average
Key checks
Key Insights
- In FY2025, sg&a per share decreased 0.6% year-over-year.
- Ranks #24 out of 156 companies in the Health Care sector.
- Peak sg&a per share was recorded in FY2024.
- Lowest sg&a per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score -0.27 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $18.71 | -0.6% |
| FY2024 | $18.82 | +53.3% |
| FY2023 | $12.28 | +24.0% |
| FY2022 | $9.90 | +76.2% |
| FY2021 | $5.62 | +20.9% |
| FY2020 | $4.65 | +8.9% |
| FY2019 | $4.27 | -6.0% |
| FY2018 | $4.54 | -25.5% |
| FY2017 | $6.09 | +8.0% |
| FY2016 | $5.64 | -19.2% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026